RNXT
RenovoRx, Inc.
Latest Form 4:Purchase$20KbyVOLL MARK (Chief Financial Officer) · filed May 21, 2026
RenovoRx, Inc. (RNXT) has 14 SEC Form 4 filings (17 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jun 24, 2026.
The most active filer is Chief Medical Officer Agah Ramtin with 5 filings.
- Industry:Biotechnology
- CEO:Shaun R. Bagai
- Employees:17
- HQ:Mountain View, CA, US
- IPO:2021-08-26
Insider Buying
$67K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$63.1M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Financial Officer | Purchase | 25,000 | $20K | May 21 | SEC ↗ | |
VOLL MARKFirst filing | Chief Financial Officer | Purchase | 97,200 | — | Mar 24 | SEC ↗ |
Marton LaurenceFirst filing | Director | Purchase | 9,720 | — | Mar 24 | SEC ↗ |
Bagai ShaunFirst in 3 months | Chief Executive Officer | Purchase | 24,300 | — | Mar 24 | SEC ↗ |
| Chief Medical Officer | Purchase | 10,000 | $10K | Jan 22 | SEC ↗ | |
| Chief Medical Officer | Purchase | 9,795 | $8K | Jan 5 | SEC ↗ | |
| Chief Medical Officer | Purchase | 205 | $169 | Jan 2 | SEC ↗ | |
| Chief Executive Officer | Purchase | 5,000 | $5K | Dec 22 | SEC ↗ | |
Bagai ShaunFirst filing | Chief Executive Officer | Purchase | 5,000 | $4K | Dec 19 | SEC ↗ |
| Chief Medical Officer | Purchase | 12,000 | $10K | Dec 17 | SEC ↗ | |
Agah RamtinFirst filing | Chief Medical Officer | Purchase | 10,000 | $10K | Dec 8 | SEC ↗ |
Related companies
RenovoRx, Inc. is in the Healthcare sector.